
Apyx Medical Corporation APYX
$ 3.7
-1.07%
Annual report 2025
added 03-10-2026
Apyx Medical Corporation Interest Expense 2011-2026 | APYX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Apyx Medical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 2.48 M | 15 K | 10 K | 46 K | 8 K | 104 K | 136 K | 158 K | 1.64 M | -7.44 M | -2.29 M | -212 K | 50 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.48 M | -7.44 M | -407 K |
Quarterly Interest Expense Apyx Medical Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 24 K | -1 K | -21 K | - | -19 K | 543 K | 234 K | - | 1 K | 3 K | 8 K | - | 3 K | 2 K | 4 K | - | 25 K | 8 K | 6 K | - | - | - | - | - | 30 K | 38 K | 34 K | - | -105 K | 2 K | 57 K | - | -720 K | -9 K | 49 K | - | -40 K | -39 K | -40 K | - | -41 K | 1.41 M | -9.63 M | - | -54 K | -23 K | -89 K | - | -58 K | -58 K | -58 K | - | -42 K | -46 K | -52 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.41 M | -9.63 M | -222 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.2 | -0.45 % | $ 3.43 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.54 | 0.86 % | $ 1.42 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.8 | -1.92 % | $ 1.92 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.78 | -12.37 % | $ 277 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.37 | 0.12 % | $ 601 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.04 | -5.28 % | $ 855 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 71.52 | 0.38 % | $ 106 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.86 | -4.93 % | $ 144 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.87 | -0.83 % | $ 1.14 B | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 64.93 | -0.12 % | $ 1.92 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.44 | -0.05 % | $ 121 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 107.89 | -2.58 % | $ 188 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.45 | -2.98 % | $ 339 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 270.01 | 0.23 % | $ 7.62 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.7 | -2.96 % | $ 392 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.1 | -3.46 % | $ 1.28 M | ||
|
AxoGen
AXGN
|
167 K | $ 31.03 | -5.25 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 173.18 | -1.67 % | $ 13 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 8.9 | -2.25 % | $ 685 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 34.44 | 2.07 % | $ 5.13 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.42 | 7.69 % | $ 43.2 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 101.65 | -1.12 % | $ 1.29 B |